Pregled bibliografske jedinice broj: 741188
Time-course of astroglial changes and cognitive decline in a rat model of sporadic Alzheimer's disease
Time-course of astroglial changes and cognitive decline in a rat model of sporadic Alzheimer's disease // Hrvatski kongres o Alzheimerovoj bolesti s međunarodnim sudjelovanjem
Brela, Hrvatska, 2014. (poster, domaća recenzija, sažetak, znanstveni)
CROSBI ID: 741188 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Time-course of astroglial changes and cognitive decline in a rat model of sporadic Alzheimer's disease
Autori
Knezović, Ana ; Šimić, Goran ; Šalković-Petrišić, Melita
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Skup
Hrvatski kongres o Alzheimerovoj bolesti s međunarodnim sudjelovanjem
Mjesto i datum
Brela, Hrvatska, 01.10.2014. - 04.10.2014
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
astrogliosis; Alzheimer; cognition; streptozotocin
Sažetak
Objectives: Cognitive decline is a major behavioural hallmark and astrogliosis is a characteristic neuropathological feature of sporadic Alzheimer's disease (sAD). Central administration of streptozotocin (STZ-icv) is shown to induce both these Alzheimer-like changes in rats due to STZ-icv rat model has been proposed as ananimal model of sAD. We have investigated the 9-month time course of cognitive decline and astrogliosis induced by 3 STZ-icv doses in this rat sAD model. Methods: Male 3 month-old Wistar rats were icv injected by STZ- (0.3, 1 and 3 mg/kg dose) or vehicle (controls) and sacrificed one, three, six or nine months after the treatment. Cognitive functions were tested by Passive Avoidance Test before sacrifice. Paraffin-embedded brain sections were immunohistochemically stained for detection of glial fibrillary acidic protein (GFAP) signal and analysed with cellSense Dimenson software. Data were analysed by Kruskal-Wallis and Mann-Whitney U test (p<0.05). Results: STZ-icv rat model demonstrated dose- and time-dependent cognitive deficits, pronounced with higher doses with acute decline after 1 month (-90%) and progressive one after 6 - 9 months (-45% to -90%). Higher STZ doses increased (+45%) the expression of GFAP positive cells acutely after 1 month, decreased (-63%) it after 6 months and then increased it (+35%) again 9 months following STZ administration. Conclusion: Results suggest that both cognitive deficit and astrogliosis induced by higher STZ-icv doses, demonstrate a biphasic pattern of appearance ; acute changes found after1 month and chronic (progressive) ones found 6-9 months after the treatment. Supported by UKF and MZOS.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
108-1080003-0020 - Mozak, eksperimentalni i cerebralni dijabetes i kognitivni i drugi poremećaji (Šalković-Petrišić, Melita, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb